SHREE GANESH REMEDIES
Back to Cashflow Statement
|
SHREE GANESH REMEDIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹24 Cr | ₹31 Cr | ₹30 Cr | ₹4.59 Cr | ₹-5.22 Cr |
What is the latest Cash Flow from Operating Activities ratio of SHREE GANESH REMEDIES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹24 Cr |
| Mar2025 | ₹31 Cr |
| Mar2024 | ₹30 Cr |
| Mar2020 | ₹4.59 Cr |
| Mar2019 | ₹-5.22 Cr |
How is Cash Flow from Operating Activities of SHREE GANESH REMEDIES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹24 Cr | -22.57 | |
| Mar2025 | ₹31 Cr | 0.71 | |
| Mar2024 | ₹30 Cr | 563.81 | |
| Mar2020 | ₹4.59 Cr | Positive | |
| Mar2019 | ₹-5.22 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹878.3 Cr | -9.1% | 22.5% | 25.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,679.0 Cr | -0.3% | -3.1% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,408.0 Cr | -1.3% | 2.2% | 57.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,634.0 Cr | -1.3% | -2.4% | 33.3% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 0.2% | -2.5% | -9.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,166.0 Cr | 3.3% | 6.1% | -6.5% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -9.1% |
22.5% |
25.6% |
| SENSEX | -3.1% |
-6.2% |
-11.7% |
You may also like the below Video Courses